Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 1
1999 1
2012 1
2013 1
2014 1
2017 1
2018 2
2019 1
2020 1
2021 1
2022 2
2023 1
2024 5
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Fixed-Dose Combination of Dapagliflozin + Sitagliptin + Metformin in Patients with Type 2 Diabetes Poorly Controlled with Metformin: Phase 3, Randomized Comparison with Dual Combinations.
Sahay RK, Giri R, Shembalkar JV, Gupta SK, Mohan B, Kurmi P, Kumar SR, Sawardekar VM, Mishra A, Murthy LS, Arya VV, Sonawane AR, Soni PN, Gofne SK, Karnawat SR, Rajurkar MN, Patel PM, Lakhwani LK, Mehta SC, Joglekar SJ. Sahay RK, et al. Among authors: murthy ls. Adv Ther. 2023 Jul;40(7):3227-3246. doi: 10.1007/s12325-023-02523-z. Epub 2023 May 31. Adv Ther. 2023. PMID: 37258803 Clinical Trial.
Fortifying Micronutrient Supplementation in India: Indian Expert consensus.
Saboo B, Gupta A, Tiwaskar M, Joshi S, Maheshwari A, Murthy LS, Panda J, Verma N, Kesavadev J, Srivastava S, Saxena D, Muruganathan A, Singh S, Sharma A. Saboo B, et al. Among authors: murthy ls. J Assoc Physicians India. 2024 Apr;72(4):81-90. doi: 10.59556/japi.72.0491. J Assoc Physicians India. 2024. PMID: 38881087
Fixed dose combination of dapagliflozin, glimepiride and extended-release metformin tablets in patients with type 2 diabetes poorly controlled by metformin and glimepiride: A phase III, open label, randomized clinical study in India.
Sahay R, Gangwani D, Singh M, Gupta S, Kale N, Srivastava M, Kurmi P, Ambaliya J, Lomte N, Gofne S, Agarwal S, Kashid P, Agarwal V, Rai P, Sharma S, Murthy LS, Rajurkar M, Saha S, Patel P, Patil D, Ghadge P, Lakhwani L, Mehta S, Joglekar SJ. Sahay R, et al. Among authors: murthy ls. Diabetes Obes Metab. 2025 Apr;27(4):2193-2205. doi: 10.1111/dom.16218. Epub 2025 Feb 14. Diabetes Obes Metab. 2025. PMID: 39950245 Free PMC article. Clinical Trial.
Efficacy of Dapagliflozin + Sitagliptin + Metformin Versus Sitagliptin + Metformin in T2DM Inadequately Controlled on Metformin Monotherapy: A Multicentric Randomized Trial.
Singh AK, Das AK, Murthy LS, Ghosal S, Sahay R, Harikumar KVS, Keshava GH, Agarwal M, Vijayakumar G, Kalra P, Lodha P, Das S, Shaikh S, Goswami S, Ajish TP, Kumthekar P, Upadhyay M, Thamburaj A, Mahule A, Prasad A, Pednekar A. Singh AK, et al. Among authors: murthy ls. Adv Ther. 2025 Feb;42(2):801-812. doi: 10.1007/s12325-024-03037-y. Epub 2024 Dec 5. Adv Ther. 2025. PMID: 39636567 Free PMC article. Clinical Trial.
Management of Hypertension in Patients with Type 2 Diabetes Mellitus: Indian Guideline 2024 by Association of Physicians of India and Indian College of Physicians.
Wander GS, Panda JK, Pal J, Mathur G, Sahay R, Tiwaskar M, Chatterjee N, Chakrabarty S, Singh DP, Murthy LS, Ghosh S, Samajdar SS, Maheswari S. Wander GS, et al. Among authors: murthy ls. J Assoc Physicians India. 2024 Aug;72(8):e1-e25. doi: 10.59556/japi.72.0620. J Assoc Physicians India. 2024. PMID: 39163066
Comparison of dual therapies for hypertension treatment in India: a randomized clinical trial.
Prabhakaran D, Roy A, Chandrasekaran AM, Kondal D, Mukherjee S, Kiru G, Singh K, Salwa H, Sobitharaj EC, Lobo AS, Mahajan G, Mohan B, Khanna A, Malviya A, Patil SG, Abichandani VK, Singh B, Gupta BK, Yellapantula B, Dandge S, Sengupta S, Kumar S, Bardoloi N, Senguttuvan NB, Sahay RK, Patil S, Deora S, Prahalad R, Sarvepalli VP, Gnanaraj JP, Khanna M, Mishra A, Aithal K, Chavda V, Cornelius VR; TOPSPIN Clinical Consortia; Poulter NR. Prabhakaran D, et al. Nat Med. 2025 Sep;31(9):3169-3175. doi: 10.1038/s41591-025-03854-w. Epub 2025 Jul 25. Nat Med. 2025. PMID: 40715816 Free PMC article. Clinical Trial.
One-year safety and effectiveness of insulin degludec in patients with diabetes mellitus in routine clinical practice in India-TRUST (Tresiba real-world use study).
Kesavadev J, Murthy LS, Chaudhury T, Yalamanchi SR, Giri J, Gupta S, Phatak S, Modi KD, Chatterjee S, Manjunath A, Revanna M, Bhattacharya A. Kesavadev J, et al. Among authors: murthy ls. Metabol Open. 2022 Apr 18;14:100184. doi: 10.1016/j.metop.2022.100184. eCollection 2022 Jun. Metabol Open. 2022. PMID: 35496980 Free PMC article.
20 results